Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-01 4:54 pm Sale | 13G | KYMERA THERAPEUTICS INC KYMR | BlackRock Inc. BLK | 3,334,901 6.1% | -62,639 (-1.84%) | View |
| 2022-08-23 4:45 pm Purchase | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 4,692,604 8.6% | 553,846 (+13.38%) | View |
| 2022-07-11 2:10 pm Purchase | 13G | KYMERA THERAPEUTICS INC KYMR | PRICE T ROWE ASSOCIATES INC | 5,224,686 10.1% | 1,674,158 (+47.15%) | View |
| 2022-06-01 5:00 pm Purchase | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 4,138,758 8% | 552,100 (+15.39%) | View |
| 2022-02-14 5:07 pm Sale | 13G | KYMERA THERAPEUTICS INC KYMR | Redmile Group LLC | 2,587,730 5% | -132,759 (-4.88%) | View |
| 2022-02-14 2:34 pm Purchase | 13G | KYMERA THERAPEUTICS INC KYMR | PRICE T ROWE ASSOCIATES INC | 3,550,528 6.9% | 3,550,528 (New Position) | View |
| 2022-02-11 5:09 pm Sale | 13G | KYMERA THERAPEUTICS INC KYMR | Atlas Venture Fund X L.P. | 5,763,012 11.2% | -2,185,970 (-27.50%) | View |
| 2022-02-10 08:22 am Purchase | 13G | KYMERA THERAPEUTICS INC KYMR | VANGUARD GROUP INC | 2,957,174 5.75% | 2,957,174 (New Position) | View |
| 2022-02-09 09:22 am Sale | 13G | KYMERA THERAPEUTICS INC KYMR | FMR LLC | 2,347,527 4.568% | -94,533 (-3.87%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | KYMERA THERAPEUTICS INC KYMR | BlackRock Inc. BLK | 3,397,540 6.6% | 3,397,540 (New Position) | View |
| 2022-02-04 09:27 am Purchase | 13G | KYMERA THERAPEUTICS INC KYMR | WELLINGTON MANAGEMENT GROUP LLP | 2,694,814 5.24% | 2,694,814 (New Position) | View |
| 2022-01-31 5:07 pm Purchase | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 3,586,658 7% | 955,996 (+36.34%) | View |
| 2021-02-16 5:27 pm Purchase | 13G | KYMERA THERAPEUTICS INC KYMR | Atlas Venture Fund X L.P. | 7,948,982 17.9% | 7,948,982 (New Position) | View |
| 2021-02-16 4:10 pm Purchase | 13G | KYMERA THERAPEUTICS INC KYMR | Redmile Group LLC | 2,720,489 6.1% | 2,720,489 (New Position) | View |
| 2021-02-08 10:27 am Purchase | 13G | KYMERA THERAPEUTICS INC KYMR | FMR LLC | 2,442,060 5.492% | 2,442,060 (New Position) | View |
| 2020-09-03 4:12 pm Purchase | 13D | KYMERA THERAPEUTICS INC KYMR | VERTEX PHARMACEUTICALS INC VRTX | 3,151,121 7.1% | 3,151,121 (New Position) | View |
| 2020-08-25 5:27 pm Purchase | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 2,630,662 5.9% | 2,630,662 (New Position) | View |